475 results on '"Takahata, Keisuke"'
Search Results
2. Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder
3. A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease
4. Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders
5. Association between mammillary body atrophy and memory impairment in retired athletes with a history of repetitive mild traumatic brain injury
6. Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain
7. Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases
8. Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects
9. Investigating neural dysfunction with abnormal protein deposition in Alzheimer’s disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography
10. Empirical likelihood inference for monotone index model
11. Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects
12. Performance of plasma Aβ42/40, measured using a fully automated immunoassay, across a broad patient population in identifying amyloid status
13. Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism
14. Bayesian Semiparametric Modeling of Response Mechanism for Nonignorable Missing Data
15. Semiparametric estimation of heterogeneous treatment effects under the nonignorable assignment condition
16. Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy
17. First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401
18. Identification and Estimation of Heterogeneous Treatment Effects under Non-compliance or Non-ignorable assignment
19. An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607)
20. Brain 5-HT2A receptor binding and its neural network related to behavioral inhibition system
21. PET-based classification of corticobasal syndrome
22. Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand, [11C]TASP457
23. Bayesian semiparametric modeling of response mechanism for nonignorable missing data
24. In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy
25. Excess tau PET ligand retention in elderly patients with major depressive disorder
26. Contributors
27. Long-term sequelae of mild-repetitive and severe traumatic brain injury: Clinical manifestations, neuropathology and diagnosis by tau PET imaging
28. A first-in-human study of 11C-MTP38, a novel PET ligand for phosphodiesterase 7
29. Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain
30. High-Contrast In Vivo Imaging of Tau Pathologies in Alzheimer’s and Non-Alzheimer’s Disease Tauopathies
31. Treatment effects on neurometabolite levels in schizophrenia: A systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
32. In vivo PET classification of tau pathologies in patients with frontotemporal dementia
33. Bayesian state-space synthetic control method for deforestation baseline estimation for forest carbon credits
34. Correction to: First‑in‑human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F‑T‑401
35. Development and Comparison of a Novel Mid‐Region Directed p‐Tau 181 Assay with Tau Positron Emission Tomography in Alzheimer’s Disease
36. In vivo characterization of tau accumulation in patients with frontotemporal dementia: A PET study with 18F‐florzolotau
37. The aftermath of boxing: Longitudinal changes of cerebral retention patterns of 18F‐florzolotau (18F‐APN‐1607) in the former professional boxers
38. Involvement of differential tau pathologies in late‐onset bipolar disorder assessed by PET with 18F‐florzolotau
39. In vivoassessment of astrocyte reactivity in patients with progressive supranuclear palsy
40. Development and Performance Assessment of a Novel Plasma p-Tau181 Assay Reflecting Tau Tangle Pathology in Alzheimer's Disease
41. Late‐life mood disorder as the initial presentation of progressive supranuclear palsy: A case series.
42. Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease.
43. Correlation of 18F-PM-PBB3 (18F-florzolotau) Tau PET Imaging with Postmortem Neuropathological Findings in A Case with Progressive Supranuclear Palsy (P9-11.015)
44. Investigating Neural Dysfunction with Abnormal Protein Deposition in Alzheimer’s Disease Through Magnetic Resonance Spectroscopic Imaging, Plasma Biomarkers, and Positron Emission Tomography
45. Altered brain energy metabolism related to astrocytes in Alzheimer′s disease
46. Discrepancy between explicit judgement of agency and implicit feeling of agency: Implications for sense of agency and its disorders
47. Behavioral evidence of delayed prediction signals during agency attribution in patients with schizophrenia
48. Estimating Density Ratio of Marginals to Joint: Applications to Causal Inference
49. A human PET study of [11C]HMS011, a potential radioligand for AMPA receptors
50. Pharmacokinetic and pharmacodynamic assessment of histamine H3 receptor occupancy by enerisant: a human PET study with a novel H3 binding ligand, [11C]TASP457
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.